X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with ALEMBIC PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA ALEMBIC PHARMA NATCO PHARMA/
ALEMBIC PHARMA
 
P/E (TTM) x 32.5 26.5 122.6% View Chart
P/BV x 16.6 6.1 273.5% View Chart
Dividend Yield % 0.7 0.8 88.8%  

Financials

 NATCO PHARMA   ALEMBIC PHARMA
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
ALEMBIC PHARMA
Mar-16
NATCO PHARMA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs877792 110.8%   
Low Rs424443 95.6%   
Sales per share (Unadj.) Rs223.4167.0 133.8%  
Earnings per share (Unadj.) Rs31.138.2 81.4%  
Cash flow per share (Unadj.) Rs40.342.0 95.9%  
Dividends per share (Unadj.) Rs5.004.00 125.0%  
Dividend yield (eoy) %0.80.6 118.7%  
Book value per share (Unadj.) Rs219.584.9 258.5%  
Shares outstanding (eoy) m33.07188.52 17.5%   
Bonus/Rights/Conversions PA--  
Price / Sales ratio x2.93.7 78.7%   
Avg P/E ratio x20.916.2 129.4%  
P/CF ratio (eoy) x16.114.7 109.8%  
Price / Book Value ratio x3.07.3 40.7%  
Dividend payout %16.110.5 153.5%   
Avg Mkt Cap Rs m21,504116,383 18.5%   
No. of employees `000NANA-   
Total wages/salary Rs m1,1284,214 26.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m7,38931,487 23.5%  
Other income Rs m16755 303.3%   
Total revenues Rs m7,55631,542 24.0%   
Gross profit Rs m1,79310,060 17.8%  
Depreciation Rs m304722 42.2%   
Interest Rs m36637 995.1%   
Profit before tax Rs m1,2909,356 13.8%   
Minority Interest Rs m460-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3092,160 14.3%   
Profit after tax Rs m1,0277,194 14.3%  
Gross profit margin %24.331.9 76.0%  
Effective tax rate %23.923.1 103.7%   
Net profit margin %13.922.8 60.9%  
BALANCE SHEET DATA
Current assets Rs m3,68115,066 24.4%   
Current liabilities Rs m3,1237,674 40.7%   
Net working cap to sales %7.623.5 32.2%  
Current ratio x1.22.0 60.1%  
Inventory Days Days8967 133.6%  
Debtors Days Days5941 144.4%  
Net fixed assets Rs m7,6858,237 93.3%   
Share capital Rs m331377 87.7%   
"Free" reserves Rs m6,67015,416 43.3%   
Net worth Rs m7,25916,005 45.4%   
Long term debt Rs m9550-   
Total assets Rs m11,95724,594 48.6%  
Interest coverage x4.5255.2 1.8%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.61.3 48.3%   
Return on assets %11.729.4 39.6%  
Return on equity %14.244.9 31.5%  
Return on capital %20.758.7 35.3%  
Exports to sales %39.455.7 70.6%   
Imports to sales %5.710.4 54.7%   
Exports (fob) Rs m2,90817,551 16.6%   
Imports (cif) Rs m4213,283 12.8%   
Fx inflow Rs m3,44517,811 19.3%   
Fx outflow Rs m7035,318 13.2%   
Net fx Rs m2,74312,493 22.0%   
CASH FLOW
From Operations Rs m1,4409,304 15.5%  
From Investments Rs m-1,089-3,105 35.1%  
From Financial Activity Rs m-353-1,959 18.0%  
Net Cashflow Rs m-14,240 -0.0%  

Share Holding

Indian Promoters % 52.0 74.1 70.2%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 2.9 270.3%  
FIIs % 16.6 9.1 182.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 13.9 187.1%  
Shareholders   25,395 49,328 51.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   SUVEN LIFE  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  SUN PHARMA  

Compare NATCO PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Infosys Woes, Insurance IPOs and Top Stocks in Action(Pre-Open)

On Monday, the share markets in India slumped in the final hours of trade and finished the day in red.The BSE Sensex closed lower by 266 points to end at 31,259.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Aug 21, 2017 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - SANOFI INDIA COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS